Indefinite Delivery Contract 75F40121D00021
Award Date
7/29/21
Last Date to Order
7/28/26
Federal Agency
Food and Drug Administration
Awardee
Biomerieux Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Biomerieux Inc. The contract has a ceiling value of $2,703,976 and a period of performance from July 2010 to July 2015. Biomerieux, through its Biomerieux, Inc. division, is a global leader in in vitro diagnostics and specializes in microbiological testing solutions. Under this IDC, Biomerieux is providing the FDA...
This indefinite delivery contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Biomerieux Inc., a global leader in in vitro diagnostics. The $640,000 single-award IDC facilitates the continued procurement of Biomerieux's specialized clinical diagnostic products and services to meet the FDA's testing needs. Under this IDC, Biomerieux has received a series of firm-fixed-price delivery orders to provide the FDA with a variety of its proprietary...
The Federal Indefinite Delivery Contract 75F40121D00012 was awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Biomerieux Inc., a manufacturer of in-vitro diagnostic solutions. The contract, with a ceiling value of $1,975,291.65, is for the provision of preventive maintenance, annual calibrations, and equipment upgrades for the FDA's fleet of Vitek and Vidas laboratory instruments used in their Office of Regulatory Affairs (ORA) and Office of Regulatory...
Biomerieux Inc., a global leader in in vitro diagnostics, holds a $194 million Federal Supply Schedule contract (FSS-65-VII) with the U.S. federal government for the provision of in-vitro diagnostic products, reagents, and test kits. Under this IDV, Biomerieux has received numerous firm-fixed-price delivery order contracts from agencies such as the Department of Veterans Affairs, Indian Health Service, and Department of Defense to supply its proprietary diagnostic platforms, including the...
This indefinite delivery contract was awarded by the Department of the Army Medical Command to Biomerieux Inc., a global leader in in vitro diagnostics and microbiology testing solutions. The contract has a potential value of $3,115,077.60 and facilitates the continued procurement of Biomerieux's proprietary clinical diagnostic platforms, reagents, and services to meet federal testing needs. The task orders issued to date have been for the company's SENSI CARD product, a firm-fixed-price,...
Biomerieux Inc., a global leader in in vitro diagnostics, has been awarded a $51,627,932 Federal Supply Schedule contract by the General Services Administration to provide a wide range of medical diagnostic products and services to various federal agencies. Through this contract, Biomerieux will deliver its specialized diagnostic platforms, reagents, test kits, and technical support for infectious disease testing and pathogen detection capabilities across government healthcare operations,...
This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Army Medical Command (MEDCOM) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at up to $1,501,969.18, is for the supply of microbial identification (ID) and antibiotic susceptibility testing (AST) cards and reagents to support infectious disease testing and pathogen detection across government healthcare operations. The contract includes multiple delivery orders issued from October 2017...
The Department of Health and Human Services Food and Drug Administration awarded a single-award Indefinite Delivery Contract to Illumina, Inc. with a potential value of $25 million. The contract provides Illumina Reagent Chemistry Kits to support the FDA's laboratory testing needs across multiple places of performance from November 2022 through January 2028. Task orders issued against the IDV by the FDA to Illumina total over $3.5 million and include delivery of reagent kits to locations such as...
This federal contract Indefinite Delivery Vehicle (IDV) was awarded by the Medical Command agency, a defense agency, to Biomerieux Inc. through its Biomerieux, Inc. division. The IDV has a total ceiling value of $213,110 and a period of performance through September 30, 2020. Under this single-award IDV, the agency has issued multiple firm-fixed-price delivery orders for an "Automated Nucleic Acid Extraction System," with a total value of $43,310 per order. The place of performance for...
This single-award Indefinite Delivery Contract (IDC) was issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to Biomerieux Inc., a global diagnostics manufacturer, to provide an Automated Blood Culture System and associated reagents. The $2,000,000 contract has a period of performance through September 30, 2025. Biomerieux will deliver its proprietary VITEK, BioFire, and VIDAS platforms, consumables, and technical support services to support...